Heinrich Dreismann is Director at MYRIAD GENETICS INC (MYGN). They have made 5 open-market trades across 1 company since 2013, most recently 2026-06-04.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYGN | SELL | 2024-09-09 | 2024-09-09 | $27.05 | $271K | +4.9% | -9.7% | -44.8% |
| MYGN | SELL | 2017-12-11 | 2017-12-12 | $33.50 | $201K | +5.6% | +9.6% | +1.9% |
| MYGN | SELL | 2015-11-05 | 2015-11-05 | $44.44 | $1.3M | -0.5% | +0.9% | -14.1% |
| MYGN | SELL | 2014-02-18 | 2014-02-20 | $35.00 | $1.1M | -0.5% | +0.9% | +0.9% |
| MYGN | SELL | 2013-05-10 | 2013-05-10 | $31.16 | $935K | -0.5% | +0.9% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.